Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer (Q35677725)
Jump to navigation
Jump to search
scientific article published on 2 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer |
scientific article published on 2 December 2014 |
Statements
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer (English)
L Bazzola
C Foroni
V Zanoni
M R Cappelletti
G Allevi
S Aguggini
C Strina
M Milani
S Venturini
F Ferrozzi
R Giardini
R Bertoni
H Turley
K Gatter
P G Petronini
M Martinotti
A Berruti
A Bottini
A R Reynolds
D Generali
2 December 2014
1 reference
1 reference
1 reference